Death row convict awake after 2 lethal injection doses. How did Christa Pike survive?

Christa Pike regained consciousness after Tennessee authorities gave her two pentobarbital doses during a failed execution. The case has raised fresh questions about whether the drug entered her bloodstream properly and about the risks of lethal injection.

In Short

• Pike regained consciousness and began speaking nearly a week after execution attempt
• Doctors say survival may mean the drug never fully entered bloodstream
• Blisters suggest possible extravasation, with pentobarbital leaking into tissue under skin

Christa Pike, a convicted murderer in the US state of Tennessee, has regained consciousness and started speaking from a hospital bed, almost a week after authorities failed twice to execute her using lethal injection.

Pike became critically ill after receiving two doses of the drug pentobarbital during the attempted execution.

Her lawyers say she is now awake and communicating. Medical experts advising her defence have described her survival as medically unprecedented.

So how could someone survive a drug dose intended to cause death?

The answer may lie not in Pike’s resistance to the drug, but in whether the drug actually reached her bloodstream in sufficient amounts.

WHAT IS PENTOBARBITAL?

Pentobarbital belongs to a class of drugs called barbiturates. It strongly depresses the central nervous system, slowing brain activity, breathing and other vital functions.

At very high doses, it can suppress the brain's control of breathing so severely that oxygen levels fall and the heart eventually stops.

In lethal injection, the drug is intended to enter a vein and rapidly reach the bloodstream. But experts say that may not have happened properly in Pike's case.

A PROBLEM WITH THE VEIN?

Dr Joel Zivot, an anaesthesiologist advising Pike's defence team, told BBC that the amount of pentobarbital administered would ordinarily have been enough to kill a person if it had entered the bloodstream normally.

However, Pike reportedly developed blisters around the injection site.

One possible explanation is that the vein ruptured or the needle was no longer properly positioned inside the vein. Instead of flowing directly into the bloodstream, the drug may therefore have leaked into the surrounding tissue under the skin.

This is known as extravasation, when a drug intended for a vein escapes into nearby tissue.

If that happened, the body would absorb the drug much more slowly and potentially in smaller amounts at any given time. That could prevent the extremely high blood concentration needed to cause death.

COULD BLOOD CLOTS HAVE PLAYED A ROLE?

Pike also has thrombocytosis, a condition in which the body produces an unusually high number of platelets. Platelets help blood clot.

Zivot has suggested that clotting around the injection site could potentially have further interfered with the drug entering the bloodstream. However, this remains a hypothesis, not an established explanation for what happened.

Another possibility is that the drug itself had degraded because of manufacturing or storage problems.

Tennessee's correction department has not specifically addressed the allegation from Pike's legal team that the pentobarbital was degraded, saying instead that the chemical used has consistently been effective.

WHY THE CASE IS UNUSUAL

Experts stress that many questions remain unanswered. It is not yet known exactly how much pentobarbital entered Pike's bloodstream, what concentration reached her blood or what long-term effects she may experience.

Pike's survival does not mean lethal injection is generally survivable.

Pentobarbital in sufficiently high concentrations can be fatal. Rather, the extraordinary question is whether the drug ever reached the levels required to cause death.

Her case is now drawing renewed attention to the medical risks and uncertainties surrounding lethal injection, including whether failed intravenous access can turn an intended rapid death into a prolonged medical emergency.

- Ends